The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Biologic treatment of rheumatoid arthritis and the risk of malignancy: Analyses from a large US observational study
Abstract
Objective: Induction of malignancy is a major concern when rheumatoid arthritis (RA) is treated with biologic therapy. A meta‐analysis of RA biologic clinical trials found a general increased risk of malignancy, but this risk was not found in a large observational study. We undertook this study to assess the risk of malignancy among biologic‐treated patients in a large US observational database. Methods: We studied incident cases of cancer among 13,001 patients during ∼49,000 patient‐years of observation in the years 1998–2005. Cancer rates were compared with population rates using the US National Cancer Institute SEER (Surveillance, Epidemiology, and End‐Results) database. Assessment of the risk of biologic therapy utilized conditional logistic regression to calculate odds ratios (ORs) as estimates of the relative risk, further adjusted for 6 confounders: age, sex, education level, smoking history, RA severity, and prednisone use. Results: Biologic exposure was 49%. There were 623 incident cases of nonmelanotic skin cancer and 537 other cancers. The standardized incidence ratios and 95% confidence intervals (95% CIs) compared with SEER data were as follows: all cancers 1.0 (1.0–1.1), breast 0.8 (0.6–0.9), colon 0.5 (0.4–0.6), lung 1.2 (1.0–1.4), lymphoma 1.7 (1.3–2.2). Biologics were associated with an increased risk of nonmelanotic skin cancer (OR 1.5, 95% CI 1.2–1.8) and melanoma (OR 2.3, 95% CI 0.9–5.4). No other malignancy was associated with biologic use; the OR (overall risk) of any cancer was 1.0 (95% CI 0.8–1.2). Conclusion: Biologic therapy is associated with increased risk for skin cancers, but not for solid tumors or lymphoproliferative malignancies. These associations were consistent across different biologic therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of patient outcome in arthritis
Fries, J. F., Spitz, P., Kraines, R. G., & Holman, H. R. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230202 · Cited by 4,382
Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I., Matteson, E. L., & Montori, V. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,468
Klareskog, L., Stolt, P., Lundberg, K., Källberg, H., Bengtsson, C., Grunewald, J., Rönnelid, J., Erlandsson Harris, H., Ulfgren, A., Rantapää‐Dahlqvist, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21575 · Cited by 1,515
The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales.
Fries, J. F., Spitz, P. W., & Young, D. Y. (1982) · PubMed · Cited by 1,318
Cancer after Kidney Transplantation in the United States
Kasiske, B. L., Snyder, J. J., Gilbertson, D. T., & Wang, C. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00450.x · Cited by 1,071
Baecklund, E., Iliadou, A., Askling, J., Ekbom, A., Backlin, C., Granath, F., Catrina, A. I., Rosenquist, R., Feltelius, N., Sundström, C., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21675 · Cited by 890
Jensen, P., Hansen, S., Møller, B., Leivestad, T., Pfeffer, P., Geiran, O., Fauchald, P., & Simonsen, S. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70185-4 · Cited by 871
INCIDENCE OF SKIN CANCER AFTER RENAL TRANSPLANTATION IN THE NETHERLANDS
HARTEVELT, M. M., BAVINCK, J. N. B., KOOTTE, A. M. M., VERMEER, B. J., & VANDENBROUCKE, J. P. (1990) · Transplantation · doi:10.1097/00007890-199003000-00006 · Cited by 694
Wolfe, F., & Michaud, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20311 · Cited by 644
Self-citationThe prevalence and meaning of fatigue in rheumatic disease.
Wolfe, F., Hawley, D. J., & Wilson, K. (1996) · PubMed · Cited by 641
Self-citationCancer risk after renal transplantation in the nordic countries, 1964–1986
Birkeland, S. A., Storm, H. H., Lamm, L. U., Barlow, L., Blohmé, I., Forsberg, B., Eklund, B., Fjeldborg, O., Friedberg, M., Frödin, L., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600209 · Cited by 613
Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy
Wolfe, F., Michaud, K., Anderson, J., & Urbansky, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20009 · Cited by 431
Self-citationMariette, X. (2002) · Blood · doi:10.1182/blood.v99.11.3909 · Cited by 428
Geborek, P., Bladström, A., Turesson, C., Gulfe, A., Petersson, I. F., Saxne, T., Olsson, H., & Jacobsson, L. T. H. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.030528 · Cited by 427
Askling, J., Fored, C. M., Baecklund, E., Brandt, L., Backlin, C., Ekbom, A., Sundström, C., Bertilsson, L., Cöster, L., Geborek, P., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.033241 · Cited by 417
Baecklund, E., Ekbom, A., Sparén, P., Feltelius, N., & Klareskog, L. (1998) · BMJ · doi:10.1136/bmj.317.7152.180 · Cited by 394
Rheumatoid arthritis and cancer risk
Mellemkjær, L., Linet, M. S., Gridley, G., Frisch, M., Møller, H., & Olsen, J. H. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00210-9 · Cited by 383
Askling, J., Fored, C. M., Brandt, L., Baecklund, E., Bertilsson, L., Feltelius, N., Cöster, L., Geborek, P., Jacobsson, L. T., Lindblad, S., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.033993 · Cited by 377
Wolfe, F., & Michaud, K. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.09.039 · Cited by 372
Self-citationIncrease in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis.
Wolfe, F., Freundlich, B., & Straus, W. L. (2003) · PubMed · Cited by 355
Self-citationRisk of malignancy among patients with rheumatic conditions
Thomas, E., Brewster, D. H., Black, R. J., & Macfarlane, G. J. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001101)88:3<497::aid-ijc27>3.0.co;2-j · Cited by 332
Estimates of Global and Regional Smoking Prevalence in 1995, by Age and Sex
Jha, P., Ranson, M. K., Nguyen, S. N., & Yach, D. (2002) · American Journal of Public Health · doi:10.2105/ajph.92.6.1002 · Cited by 316
Radis, C. D., Kahl, L. E., Baker, G. L., Wasko, M. C. M., Cash, J. M., Gallatin, A., Stolzer, B. L., Agarwal, A. K., Medsger, T. A., & Kwoh, C. K. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380815 · Cited by 314
Impact of Reporting Delay and Reporting Error on Cancer Incidence Rates and Trends
Clegg, L. X. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.20.1537 · Cited by 278
Silman, A. J., Petrie, J., Hazleman, B., & Evans, S. J. (1988) · Annals of the Rheumatic Diseases · doi:10.1136/ard.47.12.988 · Cited by 276
Michaud, K., Messer, J., Choi, H. K., & Wolfe, F. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11439 · Cited by 271
Self-citationWolfe, F., & Michaud, K. D. (2004) · PubMed · Cited by 262
Self-citationRisk of breast cancer in female flight attendants: a population-based study (Iceland)
Rafnsson, V., Tulinius, H., Jónasson, J. G., & Hrafnkelsson, J. (2001) · Cancer Causes & Control · doi:10.1023/a:1008983416836 · Cited by 227
Risk of Serious Infections and Malignancies With Anti-TNF Antibody Therapy in Rheumatoid Arthritis
Okada, S., & Siegel, J. N. (2006) · JAMA · doi:10.1001/jama.296.18.2201-b · Cited by 134
Wolfe, F., Michaud, K. D., & Pincus, T. (2005) · PubMed · Cited by 129
Self-citationMalignancy After Renal Transplantation: Incidence and Role of Type of Immunosuppression
Tremblay, F. M., Fernandes, M., Habbab, F., de Edwardes, M. D. B., Loertscher, R., & Meterissian, S. H. (2002) · Annals of Surgical Oncology · doi:10.1007/bf02574501 · Cited by 105
Baldini, E. H., & Strauss, G. M. (1997) · CHEST Journal · doi:10.1378/chest.112.4_supplement.229s · Cited by 101
Doody, M. M., Hayes, H. M., & Bilgrad, R. (2001) · Annals of Epidemiology · doi:10.1016/s1047-2797(00)00177-0 · Cited by 79
Dixon, W. G., & Silman, A. J. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2026 · Cited by 52
Risk of Serious Infections and Malignancies With Anti-TNF Antibody Therapy in Rheumatoid Arthritis
Costenbader, K. H., Glass, R. J., Cui, J., & Shadick, N. A. (2006) · JAMA · doi:10.1001/jama.296.18.2201-a · Cited by 29
Matteson, E. L., Bongartz, T., Sutton, A. J., & Buchan, I. E. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2033 · Cited by 4
Cited by
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Gottlieb, A., Feldman, S. R., Van Voorhees, A. S., Leonardi, C. L., Gordon, K. B., Lebwohl, M., Koo, J. Y. M., Elmets, C. A., Korman, N. J., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.039 · Cited by 1,222
Inflammation and cancer: advances and new agents
Crusz, S. M., & Balkwill, F. R. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.105 · Cited by 1,184
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Fleischmann, R., Kremer, J., Cush, J., Schulze-Koops, H., Connell, C. A., Bradley, J. D., Gruben, D., Wallenstein, G. V., Zwillich, S. H., & Kanik, K. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109071 · Cited by 1,024
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
van Vollenhoven, R. F., Fleischmann, R., Cohen, S., Lee, E. B., García Meijide, J. A., Wagner, S., Forejtova, S., Zwillich, S. H., Gruben, D., Koncz, T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112072 · Cited by 945
Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
Lin, Y.-J., Anzaghe, M., & Schülke, S. (2020) · Cells · doi:10.3390/cells9040880 · Cited by 932
Metadata
- Authors
- Wolfe, F., & Michaud, K.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2007-08-29
- Volume
- 56
- Issue
- 9
- Pages
- 2886-2895
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2028672514
- Cited by
- 534
- References
- 36
- FWCI
- 29.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.